ERBA Diagnostics (ERB Posts Surprise Q1 Loss

ERBA Diagnostics (NYSE: ERB) reported Q1 EPS of ($0.02), $0.03 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $4.9 million versus the consensus estimate of $4.85 million.

For earnings history and earnings-related data on ERBA Diagnostics (ERB) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance